MedTrace Logo

Fluorescence-navigated Thoracoscopy for Detection of Small Pulmonary Nodules

NCT04165603 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 352

Last updated 2019-11-18

No results posted yet for this study

Summary

Fluorescence-navigated thoracoscopic imaging with indocyanine green (ICG) is a novel technique for detection of small pulmonary nodules other than traditional radiography or intraoperative palpation. As a non-targeted fluorescent contrast agent, ICG accumulates in tumors by the enhanced permeability and retention effect (EPR), making the lesions fluoresce under fluorescent imaging. However, the optimal dosage and injection time of ICG are still under exploration. Hence, we perform this study in humans made up of four groups to determine the optimal time and dose.

Conditions

  • Pulmonary Nodule, Solitary
  • Pulmonary Nodule, Multiple

Interventions

PROCEDURE

Preoperative Infusion of Indocyanine Green

preoperatively infuse indocyanine green through peripheral vein

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Wang Jun, MD · Peking University People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04165603 on ClinicalTrials.gov